Genome-wide study of longitudinal brain imaging measures of multiple sclerosis progression across six clinical trials

Genome-wide study of longitudinal brain imaging measures of multiple sclerosis progression across six clinical trials

Abstract While the genetics of MS risk susceptibility are well-described, and recent progress has been made on the genetics of disease severity, the genetics of disease progression remain elusive. We therefore investigated the genetic determinants of MS progression on longitudinal brain MRI: change...

Full description

Bibliographic Details
Main Authors: Stephanie J. Loomis, Nilanjana Sadhu, Elizabeth Fisher, Arie R. Gafson, Yunfeng Huang, Chengran Yang, Emily E. Hughes, Eric Marshall, Ann Herman, Sally John, Heiko Runz, Xiaoming Jia, Tushar Bhangale, Paola G. Bronson
Format: Article
Language:English
Published: Nature Portfolio 2023-08-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-023-41099-0

Internet

https://doi.org/10.1038/s41598-023-41099-0

Similar Items